Great Lakes Advisors LLC Acquires New Position in Bath & Body Works, Inc. (NYSE:BBWI)

Great Lakes Advisors LLC bought a new position in Bath & Body Works, Inc. (NYSE:BBWIFree Report) during the fourth quarter, according to its most recent 13F filing with the SEC. The institutional investor bought 5,342 shares of the company’s stock, valued at approximately $207,000.

Other institutional investors have also modified their holdings of the company. EverSource Wealth Advisors LLC grew its stake in Bath & Body Works by 109.7% in the fourth quarter. EverSource Wealth Advisors LLC now owns 1,629 shares of the company’s stock worth $63,000 after purchasing an additional 852 shares in the last quarter. Sequoia Financial Advisors LLC grew its position in shares of Bath & Body Works by 40.5% during the 4th quarter. Sequoia Financial Advisors LLC now owns 9,149 shares of the company’s stock worth $355,000 after buying an additional 2,635 shares in the last quarter. Zurcher Kantonalbank Zurich Cantonalbank increased its stake in shares of Bath & Body Works by 32.6% during the fourth quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 52,784 shares of the company’s stock valued at $2,046,000 after buying an additional 12,964 shares during the period. PNC Financial Services Group Inc. raised its holdings in shares of Bath & Body Works by 5.5% in the fourth quarter. PNC Financial Services Group Inc. now owns 88,423 shares of the company’s stock valued at $3,428,000 after acquiring an additional 4,625 shares in the last quarter. Finally, Lindbrook Capital LLC lifted its stake in Bath & Body Works by 81.9% in the fourth quarter. Lindbrook Capital LLC now owns 957 shares of the company’s stock worth $37,000 after acquiring an additional 431 shares during the period. 95.14% of the stock is owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

A number of research analysts have commented on BBWI shares. Cowen reissued a “buy” rating on shares of Bath & Body Works in a research report on Thursday, February 27th. Raymond James reissued an “outperform” rating and issued a $46.00 price objective (up previously from $42.00) on shares of Bath & Body Works in a research note on Tuesday, February 25th. Piper Sandler increased their target price on Bath & Body Works from $36.00 to $39.00 and gave the company a “neutral” rating in a research report on Monday, January 6th. Deutsche Bank Aktiengesellschaft boosted their price target on Bath & Body Works from $51.00 to $52.00 and gave the stock a “buy” rating in a research report on Tuesday, November 26th. Finally, Barclays lowered their price target on shares of Bath & Body Works from $43.00 to $38.00 and set an “equal weight” rating on the stock in a report on Monday, March 3rd. Five analysts have rated the stock with a hold rating and thirteen have given a buy rating to the company’s stock. Based on data from MarketBeat, Bath & Body Works has an average rating of “Moderate Buy” and a consensus price target of $45.06.

Get Our Latest Stock Analysis on BBWI

Bath & Body Works Stock Performance

Shares of BBWI stock opened at $29.54 on Monday. Bath & Body Works, Inc. has a fifty-two week low of $26.21 and a fifty-two week high of $52.99. The firm has a market capitalization of $6.40 billion, a PE ratio of 7.20, a P/E/G ratio of 0.92 and a beta of 1.89. The stock’s 50-day simple moving average is $36.36 and its 200-day simple moving average is $34.00.

Bath & Body Works (NYSE:BBWIGet Free Report) last posted its quarterly earnings results on Thursday, February 27th. The company reported $2.09 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.04 by $0.05. The company had revenue of $2.79 billion during the quarter, compared to analyst estimates of $2.78 billion. Bath & Body Works had a net margin of 12.43% and a negative return on equity of 44.03%. Sell-side analysts forecast that Bath & Body Works, Inc. will post 3.3 earnings per share for the current year.

Bath & Body Works declared that its Board of Directors has authorized a stock repurchase plan on Thursday, February 27th that authorizes the company to buyback $500.00 million in shares. This buyback authorization authorizes the company to purchase up to 6.4% of its stock through open market purchases. Stock buyback plans are typically an indication that the company’s management believes its shares are undervalued.

Bath & Body Works Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Friday, March 7th. Shareholders of record on Friday, February 21st were issued a $0.20 dividend. This represents a $0.80 annualized dividend and a yield of 2.71%. The ex-dividend date of this dividend was Friday, February 21st. Bath & Body Works’s payout ratio is 21.98%.

Bath & Body Works Company Profile

(Free Report)

Bath & Body Works, Inc is a specialty retailers and home to America’s Favorite Fragrances, offering a breadth of exclusive fragrances for the body and home, including the selling collections for fine fragrance mist, body lotion and body cream, 3-wick candles, home fragrance diffusers and liquid hand soap.

See Also

Want to see what other hedge funds are holding BBWI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Bath & Body Works, Inc. (NYSE:BBWIFree Report).

Institutional Ownership by Quarter for Bath & Body Works (NYSE:BBWI)

Receive News & Ratings for Bath & Body Works Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bath & Body Works and related companies with MarketBeat.com's FREE daily email newsletter.